Home › Funds › TRITONPOINT WEALTH, LLC › ABT

TRITONPOINT WEALTH, LLC position in ABT

ABBOTT LABORATORIES · Health Care

TRITONPOINT WEALTH, LLC reported holding 50,312 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.49% of its reported portfolio and ranking #45 among its reported holdings. TRITONPOINT WEALTH, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)50.31K sh
Reported value held$4.97M
Portfolio Weight0.49%
First reportedQ4 2023
Last changeHold
Updated2026-10-19

Last updated: 2026-10-19 · Source: SEC EDGAR Form 13F-HR

How TRITONPOINT WEALTH, LLC's ABT position evolved

TRITONPOINT WEALTH, LLC first disclosed a stake in ABT in Q4 2023 at 64,999 shares (US$7.2M). The position peaked in Q2 2025 at 59,105 shares, worth US$8.0M. Across 12 filings, TRITONPOINT WEALTH, LLC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 50,312 shares valued at US$5.0M.

Quarter by quarter

QuarterSharesValueChange
Q4 2023 65.00K $7.15M New
Q1 2024 58.68K $6.50M Reduce
Q2 2024 56.77K $5.90M Reduce
Q3 2024 56.71K $6.38M Hold
Q4 2024 57.35K $6.49M Add
Q1 2025 57.39K $7.61M Hold
Q2 2025 59.10K $8.04M Add
Q3 2025 56.04K $7.51M Reduce
Q4 2025 54.57K $6.84M Reduce
Q1 2026 53.04K $5.45M Reduce
Q2 2026 50.24K $4.56M Reduce
Q3 2026 50.31K $4.97M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has TRITONPOINT WEALTH, LLC held ABT?

TRITONPOINT WEALTH, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is TRITONPOINT WEALTH, LLC's current position in ABT?

As of Q3 2026, TRITONPOINT WEALTH, LLC holds 50.31K shares of ABT (ABBOTT LABORATORIES), valued at $4.97M, representing 0.49% of its reported portfolio and ranking #45.

Has TRITONPOINT WEALTH, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), TRITONPOINT WEALTH, LLC held unchanged its position in ABT. The position peaked in Q2 2025 at 59.10K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.